UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000008893
Receipt No. R000010433
Official scientific title of the study Japan multicenter cohort study to FIND predictors of common palliative treatments: J-FIND
Date of disclosure of the study information 2012/09/11
Last modified on 2016/04/11 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Japan multicenter cohort study to FIND predictors of common palliative treatments: J-FIND
Title of the study (Brief title) J-FIND1
Region
Japan

Condition
Condition Cancer
Classification by specialty
Hematology and clinical oncology Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To identify the factors contributing to communication levels after morphine for refractory dyspnea
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Phase IV

Assessment
Primary outcomes Communication Capacity Scale
Key secondary outcomes Death, Glasgow Coma Scale

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1 Adult
2 Advanced cancer
3 Morphine for refractory dyspnea
4 Receivinfg specialied palliative care services
5 STAS-J of 2 or more
6 ECOG PS of 3 or 4
7 CCS of 2 or less
Key exclusion criteria 1 Medical contraindication to morphine
2 Drainage of pleural effusion
Target sample size 80

Research contact person
Name of lead principal investigator Masanori Mori
Organization Seirei Hamamatsu General Hospital
Division name Pallaitive Medicine
Address 2-12-12, Sumiyoshi, Naka-ku, Hamamatsu, Shizuoka
TEL 053-474-2222
Email Masanori.Mori@sis.seirei.or.jp

Public contact
Name of contact person Masanori Mori
Organization Seirei Hamamatsu General Hospital
Division name Pallaitive Medicine
Address 2-12-12, Sumiyoshi, Naka-ku, Hamamatsu, Shizuoka
TEL 053-474-2222
Homepage URL
Email Masanori.Mori@sis.seirei.or.jp

Sponsor
Institute Seirei Hamamatsu General Hospital
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Ministry of Health, Lavor and Welfare
Organization
Division
Category of Funding Organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 国立病院機構 大阪医療センター
大阪市立総合医療センター
大阪府立成人病センター
彩都友紘会病院
近畿中央胸部疾患センター
和歌山県立医科大学附属病院
兵庫県立がんセンター
社会保険神戸中央病院
六甲病院
藤井政雄記念病院
松江市立病院
岡山済生会総合病院
広島県立広島病院
福山市民病院
施設
国立病院機構 山口宇部医療センター
松山ベテル病院
九州がんセンター
国立病院機構 都城病院
医療法人倫生会三州病院
社会医療法人友愛会 南部病院

Other administrative information
Date of disclosure of the study information
2012 Year 09 Month 11 Day

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 08 Month 17 Day
Anticipated trial start date
2012 Year 08 Month 18 Day
Last follow-up date
2015 Year 03 Month 31 Day
Date of closure to data entry
2015 Year 03 Month 31 Day
Date trial data considered complete
2015 Year 03 Month 31 Day
Date analysis concluded
2015 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Data collection completed

Management information
Registered date
2012 Year 09 Month 11 Day
Last modified on
2016 Year 04 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000010433